Pharming Group NV (PHAR)
17.42
-0.50
(-2.79%)
USD |
NASDAQ |
Jan 21, 10:36
Pharming Group Shareholders Equity (Quarterly): 264.64M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 228.75M |
| ProQR Therapeutics NV | 67.06M |
| argenx SE | -- |
| Pharvaris NV | 366.88M |
| NewAmsterdam Pharma Co. NV | 728.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 473.78M |
| Total Liabilities (Quarterly) | 209.14M |
| Debt to Equity Ratio | 0.4947 |
| Current Ratio | 3.158 |
| Net Debt Paydown Yield | 0.04% |